Target intelligence / Profile preview

Beta-defensin 121 (DEFB121)

Target: DEFB121
Molecular classification: Antimicrobial peptide, Beta-defensin family, Secreted protein, Other (innate immunity peptide)

Overview

Beta-defensin 121 (DEFB121) is a member of the beta-defensin family of secreted antimicrobial peptides, encoded by a protein-coding gene on human chromosome 20. Defensins are key components of the innate immune system, providing protection of tissues and organs by exerting broad-spectrum antibacterial activity. Beta-defensin 121 acts to disrupt microbial membranes, limiting infection and contributing to local defense, including expression in reproductive tissues where it may play a role in sperm maturation. As an antimicrobial peptide, DEFB121 is classified as part of the defensin family, but its specific contributions to disease risk or therapeutic modulation are not extensively characterized, and no drugs currently target it directly.

Other names: Beta-defensin 121DEFB121Defensin beta 121DEFB21Beta-defensin 21Defensin, beta 121Defensin, beta 21Epididymis secretory sperm binding proteinESC42RELC

Mechanism of action

Direct membrane disruption of bacteria by cationic peptide action; Broad spectrum antimicrobial effect

Biological functions

Antimicrobial activity (broad spectrum antibacterial)Defense against infection (innate immunity)

Disease associations

Infection (modulation of susceptibility and local host defense)Other (no direct evidence for roles in cancer, inflammation, or other disease categories in the provided sources)

Safety considerations

None reported specific to Beta-defensin 121; general challenges for therapeutic use of defensins may include immunogenicity or off-target effects but not documented for DEFB121.

Interacting drugs

None specified in current public databases for this defensin; defensins are not known as direct drug targets but may be considered in antimicrobial peptide therapeutics.

Biomarkers

None specified for patient selection or monitoring

Beyond the preview

Go deeper on Beta-defensin 121 (DEFB121).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-defensin 121 (DEFB121).

Explore the full profile